Tech Company Financing Transactions

Thetis Pharmaceuticals Funding Round

Connecticut Innovations, Stonehenge Capital and private investors joined a $1.5 million venture round for Thetis Pharmaceuticals. The financing round closed on 8/22/2011.

Transaction Overview

Announced On
8/22/2011
Transaction Type
Venture Equity
Amount
$1,500,000
Round
Undisclosed
Proceeds Purpose
The company expects to begin clinical studies with TP101 in 2012, an exceptionally rapid timeline made possible by certain regulatory efficiencies associated with the metformin / omega-3 chemical composition of the drug candidate.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
23 Business Park Dr.
Branford, CT 06405
USA
Email Address
Overview
Thetis Pharmaceuticals is a privately held biopharmaceutical company applying its HEALER technology to discover and develop innovative drugs for the treatment of gastrointestinal and cardiometabolic diseases.
Profile
Thetis Pharmaceuticals LinkedIn Company Profile
Social Media
Thetis Pharmaceuticals Company Twitter Account
Company News
Thetis Pharmaceuticals News
Facebook
Thetis Pharmaceuticals on Facebook
YouTube
Thetis Pharmaceuticals on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Gary Mathias
  Gary Mathias LinkedIn Profile  Gary Mathias Twitter Account  Gary Mathias News  Gary Mathias on Facebook
Chief Medical Officer
Brian Harvey
  Brian Harvey LinkedIn Profile  Brian Harvey Twitter Account  Brian Harvey News  Brian Harvey on Facebook
President
Frank Sciavolino
  Frank Sciavolino LinkedIn Profile  Frank Sciavolino Twitter Account  Frank Sciavolino News  Frank Sciavolino on Facebook
VP - Bus. Development
Aaron Mathias
  Aaron Mathias LinkedIn Profile  Aaron Mathias Twitter Account  Aaron Mathias News  Aaron Mathias on Facebook
VP - R & D
Matthew Hanley
  Matthew Hanley LinkedIn Profile  Matthew Hanley Twitter Account  Matthew Hanley News  Matthew Hanley on Facebook


 

 

Browse more venture capital transactions:

Prev: 8/22/2011: Sentilla venture capital transaction
Next: 8/22/2011: 6fusion venture capital transaction

 

Share this article

 


About Database of VC Transactions

We do our best to report on every notable VC transaction. All VC database entries reported here are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary